Hong Kong Prohibits CBD Products: 7-Year Imprisonment and Heavy Fines

Jan.12.2023

Hong Kong bans all CBD products, adding them to its Dangerous Drugs Ordinance, with the possibility of severe punishments.

Hong Kong, China recently announced that all products containing cannabidiol (CBD) will be banned starting February 1st. CBD will be added to the Dangerous Drugs Ordinance (DDO), which already includes over 200 substances such as fentanyl, ketamine, heroin, and various psychoactive compounds like MDMA.

CBD will now be included in the existing list of "cannabinol and its tetrahydro derivative (THC); as well as 3-alkyl homologues." As a result of this change, anyone who possesses or consumes CBD will face a maximum of seven years in prison and a fine of up to HKD 1 million (approximately RMB 870,000).

According to Lexology, manufacturers of CBD may also face life imprisonment.

Although many users around the world have been touting the anti-anxiety and pain-relieving properties of CBD, the Hong Kong Security Bureau believes that these claims "lack authoritative scientific evidence." This directive appears to be consistent with China's ban on the use of CBD in cosmetics implemented last year.

Currently, it is unclear whether other cannabinoids such as CBG, CBDV, CBC, etc. will be included in the ban. However, based on a memorandum from the Narcotics Division in November 2022, the Hong Kong government appears to be primarily concerned about the possibility of CBD products containing trace amounts of THC, either through breakdown or conversion, and the lack of international regulations specifically for these products.

Article Related Reading: Hong Kong plans to completely ban the sale of CBD products by the end of 2022.

#CBD #Products #Hong Kong #Hong Kong, China #Product

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Malaysia CID Endorses Nationwide Vape Ban Amid Rising Drug-Laced Vape Cases

Malaysia’s Federal Criminal Investigation Department (CID) has voiced support for a nationwide ban on vaping, particularly targeting drug-laced vape devices, to address rising abuse cases.

Oct.23 by 2FIRSTS.ai

State Tobacco Monopoly Administration Chief Meets with President of South Korean Tobacco Company Wang Gongcheng also in attendance; friendly talks held between the two parties.

State Tobacco Monopoly Administration director Zhang Jianmin met with Korean Tobacco Company president Fang Jingwan in Beijing on October 31.

Nov.03 by 2FIRSTS.ai

U.S. 25 Attorneys General Urge Shopify to Block Illegal E-Cigarette Sales

California Attorney General Rob Bonta and the City of New York co-led a bipartisan coalition of 25 attorneys general in urging Shopify Inc. to take stronger measures against merchants selling illegal e-cigarettes and other tobacco products through its platform. The letter calls for cooperation between Shopify and U.S. states to address the persistent sale of unapproved vaping products.

Nov.25 by 2FIRSTS.ai

Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.

Altria reported Q3 2025 net revenue of $6.072 billion, a 3.0% year-on-year decline. Adjusted EPS increased 3.6% to $1.45. The company expanded its share repurchase program to $2 billion and launched the on!PLUS nicotine pouch in Florida, North Carolina, and Texas.

Oct.31 by 2FIRSTS.ai